About the journal
ecancermedicalscience is an open-access journal published by ecancer in United Kingdom, publishing in english and spanish. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 GBP. Declared review time at DOAJ: 27 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- ecancer
- ISSN
- 1754-6605
- Country
- United Kingdom
- Languages
- english, spanish
- Access
- Open access
- Declared publication charge
- 1,000 GBP
- Articles in DOAJ
- 0
- Declared review time
- 27 weeks
- Declared peer-review model
- peer_review
- Official website
- https://ecancer.org/en/journal
Index listings
- DOAJ · 2008-01-04
- Indexing
- DOAJ
- APC
- 1,000 GBP
- Declared review time (DOAJ)
- 27 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
27weeks
Works in OpenAlex
2236
Last recorded publication year
2026
h-index
64
i10-index
642
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2022-11-09
- Added to DOAJ
- 2008-01-04
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- PMC
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- e cancer medical science
- Source type
- journal
- NLM unique ID (PubMed)
- 101392236
Classification3
Subjects (DOAJ)
LCC codes
Subject areas
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Advances in Oncology and Radiotherapy
- Advances in Oncology and Radiotherapy
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Cervical Cancer and HPV Research
- Cervical Cancer and HPV Research
Show all subjects (50)
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Palliative Care and End-of-Life Issues
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Palliative Care and End-of-Life Issues
- Cancer survivorship and care
- Cancer survivorship and care
- Head and Neck Cancer Studies
- COVID-19 and healthcare impacts
- Head and Neck Cancer Studies
- COVID-19 and healthcare impacts
- Childhood Cancer Survivors' Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Childhood Cancer Survivors' Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Lung Cancer Treatments and Mutations
- Endometrial and Cervical Cancer Treatments
- Lung Cancer Treatments and Mutations
- Endometrial and Cervical Cancer Treatments
- Breast Lesions and Carcinomas
- Cancer Risks and Factors
- Sarcoma Diagnosis and Treatment
- Breast Lesions and Carcinomas
- Cancer Risks and Factors
- Sarcoma Diagnosis and Treatment
- BRCA gene mutations in cancer
- BRCA gene mutations in cancer
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Ovarian cancer diagnosis and treatment
- Ovarian cancer diagnosis and treatment
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Screening and Detection
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Global Health and Surgery
- Cancer Immunotherapy and Biomarkers
- Acute Lymphoblastic Leukemia research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Keywords (DOAJ)
- chemotherapy
- molecular biology
- genetics
- pathophysiology
- epidemiology
- cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ